Through a series of preclinical studies conducted on the Alpl−/− mouse model of infantile hypophosphatasia (TNAP−/− mice), a mineral-targeted recombinant form of TNAP was developed (32, 33). The gene discussed is ALPL; the disease is hypophosphatasia.